“Now that we have officially closed on the acquisition, it is time to start realizing synergies and growing our combined businesses.''
NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces the closing of the previously announced acquisition of DERMAdoctor, LLC. The Company also announced that it will report financial results for the third quarter 2021 on Thursday November 11, 2021 and will hold an investment community conference call that day beginning at 4:30 p.m. Eastern time. “Now that we have officially closed on the acquisition, it is time to start realizing synergies and growing our combined businesses. On our conference call later this week we will discuss the many benefits we see from the DERMAdoctor acquisition in addition to detailing our third quarter financial results,” said Justin Hall, NovaBay CEO. “The timing of this earnings call allows us to recap recent accomplishments and share some detail on our strategic vision going forward.”
The Company was advised by Two Roads Advisors LLC, a boutique investment bank led by John Z. Fang and Rob Cooper, in the acquisition of DERMAdoctor.
Date/Time:Thursday, November 11, 4:30 p.m. ET / 1:30 p.m. PT Pre-Registration:Participants can pre-register for the conference call here: Callers who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time, including up to and after the call start time. Dial In:Those who choose not to pre-register can access the live conference call by dialing the following and requesting the NovaBay Pharmaceuticals call: 866-777-2509 from within the U.S. 412-317-5413 from outside the U.S.
The live webcast of the conference call also will be available at http://novabay.com/investors/events. A replay of the call will be available beginning two hours after its completion through December 2, 2021 by dialing 877-344-7529 from within the U.S., 855-669-9658 from Canada or 412-317-0088 from outside the U.S., and entering conference ID 10161592. The webcast will also be archived at http://novabay.com/investors/events.
About NovaBay Pharmaceuticals, Inc.: Going Beyond Antibiotics® NovaBay Pharmaceuticals, Inc. is pharmaceutical company that develops and sells scientifically created and clinically proven consumer products for the eyecare and skincare markets. Avenova® is the most prescribed antimicrobial lid and lash spray and CelleRx® is a breakthrough product in the beauty category. In November 2021, NovaBay acquired DERMAdoctor, LLC, a company commercializing more than 30 dermatologist-developed skincare products sold through major traditional retailers, digital beauty retailers and online to international markets through a network of international distribution and retailers.
Socialize and Stay informed on NovaBay’s progress Like us on Facebook Follow us on Twitter Connect with NovaBay on LinkedIn Visit NovaBay’s Website
Avenova Purchasing Information For NovaBay Avenova purchasing information: Please call 800-890-0329 or email email@example.com. Avenova.com